
Heparin Sodium - Anticoagulant Sulfated Glycosaminoglycan, High Purity And Quality
Get Latest Price
In Stock
Product Specifications
| CAS Number | 9041-08-1 |
| Appearance | Powder |
| Purity | 98% |
| Molecular Weight | Variable |
| Packaging | Bottle |
| Storage | Dry |
| Usage | Anticoagulant in medicine |
| Features | Anticoagulant, Pharmaceutical, High purity, Effective, Safe |
Product Overview
Key Features
CAS No.: 9041-08-01
Heparin is a heterogenous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycans having anticoagulant properties. Although others may be present, the main sugars occurring in heparin are: (1) alpha-L-iduronic acid 2-sulfate, (2) 2-deoxy-2-sulfamino- alpha-D-glucose 6-sulfate, (3) beta-D-glucuronic acid, (4) 2-acetamido-2-deoxy- alpha-D-glucose, and (5) alpha-L-iduronic acid. These sugars are present in decreasing amounts, usually in the order (2) > (1) > (4) > (3) > (5), and are joined by glycosidic linkages, forming polymers of varying sizes. Heparin is strongly acidic because of its content of covalently linked sulfate and carboxylic acid groups. In heparin sodium, the acidic protons of the sulfate units are partially replaced by sodium ions.
Usage: It is a preparation containing the sodium salt of a sulphated glucosaminoglycan present in mammalian tissues. On complete hydrolysis, it liberates D-glucosamine, D-glucuronic acid, L-iduronic acid, acetic acid and sulphuric acid.
Clients can avail this Heparin Sodium at industry leading prices from us.
Company Details
Focusing on a customer-centric approach, Italy Delta Technology Co., Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Chemicals in bulk from Italy Delta Technology Co., Ltd. at Trade India quality-assured products.
Business Type
Exporter, Manufacturer
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Xuzhou, Jiangsu
Name
Ms. Julienas
Address
weiyi road 133, Xuzhou, Jiangsu, 221000, China
heparin in Xuzhou
Report incorrect details























